A genetic variation in microRNA target site of ETS2 is associated with clinical outcomes of paclitaxel-cisplatin chemotherapy in non-small cell lung cancer.
about
A genetic variation in microRNA target site of ETS2 is associated with clinical outcomes of paclitaxel-cisplatin chemotherapy in non-small cell lung cancer.
description
2016 nî lūn-bûn
@nan
2016 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մարտին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
A genetic variation in microRN ...... in non-small cell lung cancer.
@ast
A genetic variation in microRN ...... in non-small cell lung cancer.
@en
A genetic variation in microRN ...... in non-small cell lung cancer.
@nl
type
label
A genetic variation in microRN ...... in non-small cell lung cancer.
@ast
A genetic variation in microRN ...... in non-small cell lung cancer.
@en
A genetic variation in microRN ...... in non-small cell lung cancer.
@nl
altLabel
A genetic variation in microRN ...... in non-small cell lung cancer
@en
prefLabel
A genetic variation in microRN ...... in non-small cell lung cancer.
@ast
A genetic variation in microRN ...... in non-small cell lung cancer.
@en
A genetic variation in microRN ...... in non-small cell lung cancer.
@nl
P2093
P2860
P3181
P356
P1433
P1476
A genetic variation in microRN ...... in non-small cell lung cancer.
@en
P2093
Chang Ho Kim
Cheng Cheng Jin
Hyo Jung Kang
Jae Yong Park
Jaehee Lee
Ji Woong Son
Ji Yun Jeong
Jin Eun Choi
Kyung Min Shin
Mi Jeong Hong
P2860
P304
P3181
P356
10.18632/ONCOTARGET.7433
P407
P577
2016-03-29T00:00:00Z